Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Get Free Report) has been assigned an average recommendation of “Moderate Buy” from the seventeen ratings firms that are presently covering the company, Marketbeat.com reports. Seven equities research analysts have rated the stock with a hold recommendation and ten have given a buy recommendation to the company. The average 1 […]
Alnylam Pharmaceuticals (NASDAQ:ALNY – Free Report) had its target price trimmed by Chardan Capital from $250.00 to $225.00 in a research report released on Friday, Benzinga reports. The firm currently has a buy rating on the biopharmaceutical company’s stock. ALNY has been the topic of a number of other reports. Wells Fargo & Company initiated […]
Alnylam Pharmaceuticals (NASDAQ:ALNY) Given Buy Rating at Needham & Company LLC themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Alnylam Pharmaceuticals (NASDAQ:ALNY) Stock Rating Lowered by The Goldman Sachs Group theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Dai ichi Life Insurance Company Ltd grew its holdings in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) by 7.6% during the third quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 7,100 shares of the biopharmaceutical company’s stock after buying an additional 504 shares during the period. […]